Rice William G. 4
4 · Aptose Biosciences Inc. · Filed Jul 10, 2020
Insider Transaction Report
Form 4
Rice William G.
DirectorChair, President & CEO
Transactions
- Sale
Common Shares
2020-07-10$6.05/sh−168,891$1,021,791→ 297,523 total
Footnotes (2)
- [F1]The reporting person's sale of APTO common stock reported herein (see footnote 2 below) was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 3,400 shares, with the reporting person's purchase of 3,400 shares of APTO common stock at a price of $5.8244 per share on March 25, 2020. The reporting person has agreed to pay to Aptose Biosciences Inc., upon settlement of the sale, $767.04, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.
- [F2]Represents shares automatically sold by the reporting person to satisfy tax withholding obligations in connection with the vesting of 300,000 restricted stock units, previously reported on a Form 4/A filed with the Securities and Exchange Commission on March 10, 2020.